MedPath

Dextroamphetamine

Dextroamphetamine Sulfate Oral Solution CII, 5 mg/5 mL Rx Only

Approved
Approval ID

7658071e-ee2c-4d23-94ce-1906959ec036

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 23, 2023

Manufacturers
FDA

Tris Pharma Inc

DUNS: 947472119

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Dextroamphetamine

PRODUCT DETAILS

NDC Product Code27808-085
Application NumberANDA203644
Marketing CategoryC73584
Route of AdministrationORAL
Effective DateOctober 23, 2023
Generic NameDextroamphetamine

INGREDIENTS (7)

DEXTROAMPHETAMINE SULFATEActive
Quantity: 5 mg in 5 mL
Code: JJ768O327N
Classification: ACTIB
ANHYDROUS CITRIC ACIDInactive
Code: XF417D3PSL
Classification: IACT
BENZOIC ACIDInactive
Code: 8SKN0B0MIM
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
SODIUM CITRATEInactive
Code: 1Q73Q2JULR
Classification: IACT
SACCHARINInactive
Code: FST467XS7D
Classification: IACT
SORBITOLInactive
Code: 506T60A25R
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Dextroamphetamine - FDA Drug Approval Details